WALTHAM, Mass., Aug. 3, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced its financial results for the second quarter ended June 30, 2017.
Second Quarter 2017
Total revenue was $558 million, a 9% decrease compared to $610 million in the prior year period.
Non-GAAP organic growth during the second quarter of 2017 was -7.8% and -3.6% excluding Arriva.*
